Adjuvant Therapy for High-Grade, Uterus-Limited Leiomyosarcoma: Results of a Phase 2 Trial (SARC 005) von HENSLEY, Martee L, KYLE WATHEN, J, MAKI, Robert G, ARAUJO, Dejka M, SUTTON, Gregory, PRIEBAT, Dennis A, GEORGE, Suzanne, SOSLOW, Robert A, BAKER, Laurence H

Volltext

Practical Bayesian adaptive randomisation in clinical trials von Thall, Peter F, Wathen, J. Kyle

Volltext

Phase II Multicenter Trial of Imatinib in 10 Histologic Subtypes of Sarcoma Using a Bayesian Hierarchical Statistical Model von CHUGH, Rashmi, KYLE WATHEN, J, SAMUELS, Brian L, BAKER, Laurence H, MAKI, Robert G, BENJAMIN, Robert S, PATEL, Shreyaskumar R, MYERS, Paul A, PRIEBAT, Dennis A, REINKE, Denise K, THOMAS, Dafydd G, KEOHAN, Mary L

Volltext

Efficacy of Imatinib in Aggressive Fibromatosis: Results of a Phase II Multicenter Sarcoma Alliance for Research through Collaboration (SARC) Trial von CHUGH, Rashmi, WATHEN, J. Kyle, BENJAMIN, Robert S, BAKER, Laurence H, PATEL, Shreyaskumar R, MAKI, Robert G, MEYERS, Paul A, SCHUETZE, Scott M, PRIEBAT, Dennis A, THOMAS, Dafydd G, JACOBSON, Jon A, SAMUELS, Brian L

Volltext

Phase II Study of Sequential Gemcitabine Followed by Docetaxel for Recurrent Ewing Sarcoma, Osteosarcoma, or Unresectable or Locally Recurrent Chondrosarcoma: Results of Sarcoma Al... von Fox, Elizabeth, Patel, Shreyaskumar, Wathen, J. Kyle, Schuetze, Scott, Chawla, Sant, Harmon, David, Reinke, Denise, Chugh, Rashmi, Benjamin, Robert S., Helman, Lee J.

Volltext

A platform trial approach to proof-of-concept (POC) studies in autism spectrum disorder: Autism spectrum POC initiative (ASPI) von Wathen, J. Kyle, Jagannatha, Shyla, Ness, Seth, Bangerter, Abigail, Pandina, Gahan

Volltext

Bayesian model averaging in meta-analysis: vitamin E supplementation and mortality von Berry, Donald, Wathen, J. Kyle, Newell, Margaret

Volltext

Bayesian adaptive model selection for optimizing group sequential clinical trials von Wathen, J. Kyle, Thall, Peter F.

Volltext

A simulation study of outcome adaptive randomization in multi-arm clinical trials von Wathen, J Kyle, Thall, Peter F

Volltext

A prospective, randomized, double-blind study, comparing unirradiated to irradiated white blood cell transfusions in acute leukemia patients von Freireich, E J, Lichtiger, B, Mattiuzzi, G, Martinez, F, Reddy, V, Kyle Wathen, J

Volltext

Accounting for patient heterogeneity in phase II clinical trials von Wathen, J. Kyle, Thall, Peter F., Cook, John D., Estey, Elihu H.

Volltext

Prophylaxis of Graft-Versus-Host Disease in Unrelated Donor Transplantation With Pentostatin, Tacrolimus, and Mini-Methotrexate: A Phase I/II Controlled, Adaptively Randomized Stud... von PARMAR, Simrit, ANDERSSON, Borje S, ALOUSI, Amin, CANO, Pedro, BOSQUE, Doyle, HOSING, Chitra, DE PADUA SILVA, Leandro, WESTMORELAND, Michael, WATHEN, J. Kyle, BERRY, Donald, CHAMPLIN, Richard E, DE LIMA, Marcos J, COURIEL, Daniel, MUNSELL, Mark F, FERNANDEZ-VINA, Marcelo, JONES, Roy B, SHPALL, Elizabeth J, POPAT, Uday, ANDERLINI, Paolo, GIRALT, Sergio

Volltext

SARC009: Phase 2 study of dasatinib in patients with previously treated, high‐grade, advanced sarcoma von Schuetze, Scott M., Wathen, J. Kyle, Lucas, David R., Choy, Edwin, Samuels, Brian L., Staddon, Arthur P., Ganjoo, Kristen N., von Mehren, Margaret, Chow, Warren A., Loeb, David M., Tawbi, Hussein A., Rushing, Daniel A., Patel, Shreyaskumar R., Thomas, Dafydd G., Chugh, Rashmi, Reinke, Denise K., Baker, Laurence H.

Volltext

Who wants to go first? A simulation study of accrual in a stand-alone trial versus starting a platform trial von Broglio, Kristine, Niewczas, Julia, Wathen, Kyle

Volltext

Economic Evaluation of Cost and Time Required for a Platform Trial vs Conventional Trials von Park, Jay J. H., Sharif, Behnam, Harari, Ofir, Dron, Louis, Heath, Anna, Meade, Maureen, Zarychanski, Ryan, Lee, Raymond, Tremblay, Gabriel, Mills, Edward J., Jemiai, Yannis, Mehta, Cyrus, Wathen, J. Kyle

Volltext

P3‐008: Optimal Composite Cognitive Endpoints for PRE‐Symptomatic Alzheimer’s Disease: Considerations in Bridging Across Studies von Raghavan, Nandini, Wathen, Kyle

Volltext

OPTIMAL COMPOSITE COGNITIVE ENDPOINTS FOR PRE-SYMPTOMATIC ALZHEIMER’S DISEASE: CONSIDERATIONS IN BRIDGING ACROSS STUDIES von Raghavan, Nandini, Wathen, Kyle

Volltext

Bayesian model averaging in meta-analysis: Authors' response von Berry, Donald, Wathen, J Kyle, Newell, Margaret

Volltext

Adaptive Design: Results of 2012 Survey on Perception and Use von Morgan, Caroline Claire, Huyck, Susan, Jenkins, Martin, Chen, Li, Bedding, Alun, Coffey, Christopher S., Gaydos, Brenda, Wathen, J. Kyle

Volltext

Adjuvant therapy for high‐grade, uterus‐limited leiomyosarcoma von Hensley, Martee L., Wathen, J. Kyle, Maki, Robert G., Araujo, Dejka M., Sutton, Gregory, Priebat, Dennis A., George, Suzanne, Soslow, Robert A., Baker, Laurence H.

Volltext